November 2nd, 2026Before you call it ADHD: Find the child at eightLearn how to distinguish true ADHD from anxiety, trauma, sleep issues, or substance use by tracing symptoms back to childhood across settings and impairment.Read more
October 29th, 2026CDC: ADHD diagnoses in US children rose to 13.8% from 2019 to 2025NHIS data show the share of US children aged 5 to 17 years ever diagnosed with ADHD climbed from 9.9% in 2019 to 13.8% in 2025.Read more
October 28th, 2026Self-harm risk peaks before ADHD medication initiation, study findsSelf-harm risk in ADHD peaked in the 90 days before medication initiation and declined once treatment began, a 5-system analysis found.Read more
October 22nd, 2026Low third-trimester PlGF linked to later ADHD in offspringLower maternal PlGF in the third trimester was tied to child ADHD in a University of Iowa cohort, independent of preeclampsia and FGR.Read more
November 16th, 2026Tirzepatide cuts BMI 18.5% in adolescents with obesityIn SURMOUNT-ADOLESCENTS, tirzepatide cut BMI 18.5% at 72 weeks vs a 0.5% rise with placebo in adolescents with obesity.Read more
November 16th, 2026Maternal autoantibodies linked to autism subtype, recurrence riskData presented at NSGC 2026 tie maternal autoantibody combinations to a non-genetic autism subtype with high recurrence risk in later-born siblings.Read more
November 16th, 2026Roflumilast cream 0.05% eases itch, improves QOL in infants with ADCaregivers reported itch, symptom, and QOL gains with roflumilast cream 0.05% in infants with AD; an FDA decision is due February 2027.Read more
November 16th, 2026Etavopivat for sickle cell disease submitted to FDA and EMANovo Nordisk filed etavopivat for SCD in patients aged 12+, backed by phase 3 HIBISCUS data showing a 27% drop in vaso-occlusive crises vs placebo.Read more